Recent Finacing
Recent Raise
Groove Biopharma develops minor-groove-binder–appended oligonucleotide therapeutics to modulate microRNA, using an exclusive MGB chemistry license to advance candidates through preclinical and IND-enabling studies.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
